Skip to main content
. Author manuscript; available in PMC: 2016 Nov 10.
Published in final edited form as: Circulation. 2015 Oct 2;132(19):1825–1833. doi: 10.1161/CIRCULATIONAHA.115.016759

Table 3.

Effect of statins on aldosterone and cortisol levels in repeated measures analysis adjusted by confounders in hypertensive subjects.

Adrenal hormones
1122 observations
Model 1* Model 2
Statin effect:β (Predicted change) p value Statin effect:β (Predicted change) p value
Aldosterone ng/dl (HSb, HSstim, LSb, LSstim) −4.61 (↓33%) p <0.001 −4.29 (↓32%) p <0.001
Cortisol ug/dL (HSb, HSstim, LSb, LSstim) −0.23 p =0.667 −1.64 p =0.763
Aldosterone ng/dl on HS (b,stim)§ −1.72 (↓18%) p <0.001 −1.53 (↓18%) p <0.001
Aldosterone ng/dl on LS b,stim) || −6.67 (↓35%) p <0.001 −6.17 (↓34%) p <0.001
*

Mixed Model 1: adjusted by age, BMI, gender and urinary sodium.

Mixed Model 2: covariates in model 1 plus race, site, and sodium diet order

High sodium (HS) baseline (b), HS Angiotensin II stimulation (stim), Low sodium (LS) b, LS stim (1122 observations)

§

High sodium baseline (b), HS Angiotensin II stimulation (stim) (494 observations)

||

Low sodium baseline (b), LS Angiotensin II stimulation (stim) (628 observations)